Redmile Group LLC 13D and 13G filings for ADC Therapeutics S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-24 9:31 pm Purchase | 2026-04-20 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 12,717,487 9.900% | 24,646 (+0.19%) | Filing |
| 2026-04-06 9:47 pm Sale | 2026-04-06 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 12,692,841 9.900% | -2,973,890 (-18.98%) | Filing |
| 2026-02-17 4:15 pm Unchanged | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,666,731 12.700% | 0 (Unchanged) | Filing |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,666,731 14.000% | -2,486 (-0.02%) | Filing |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,669,217 16.200% | 340,900 (+2.22%) | Filing |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,328,317 18.800% | 1,763,068 (+13.00%) | Filing |
| 2023-02-10 5:18 pm Purchase | 2022-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 13,565,249 16.800% | 6,114,220 (+82.06%) | Filing |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 7,451,029 9.700% | 692,235 (+10.24%) | Filing |